Regarding CAC, Wick et al. reported a shift from preferential STAT6 activation to STAT3 activation regarding non-cancerous and cancerous samples from IBD patients [133], respectively, suggesting that STAT6 might prevent malignant transformation or might be downregulated in a neoplastic environment. This evidence concerns the gene STAT3 and inflammatory bowel disease.